Axel Grothey, MD

Profession: Professor of Oncology; Consultant, Medical Oncology, Mayo Clinic
Member since: 2006 Dec 18

Recent Posts

Capecitabine and Oxaliplatin for Gastric Cancer After Gastrectomy

Lancet. 2012 Jan 6;[Epub Ahead of Print], YJ Bang, et al

Dr. Axel Grothey: Progress Finally—New Adjuvant Therapy for Advanced Colorectal Cancer

Interview by L Scott Zoeller. 2012 Jan 10, Axel Grothey, MD

Recurrence Risk Assay Validated for Stage II Colon Cancer

J Clin Oncol. 2011 Nov 7;[Epub Ahead of Print], RG Gray, et al

Vandetanib Effective in Advanced Medullary Thyroid Cancer

J Clin Oncol. 2011 Oct 24;[Epub Ahead of Print], SA Wells Jr, et al

Introducing "Ask the Expert"

OncologySTAT Editorial Team. 2011 Dec 6

Low Absolute Risk of Adenocarcinoma in Barrett's Esophagus

N Engl J Med. 2011 Oct 13;3651375-1383, F Hvid-Jensen, et al

Laparoscopic Liver Resection Headed for Mainstream

Elsevier Global Medical News. 2011 Apr 11, D Mahoney

Everolimus Improved PFS in Advanced Neuroendrocrine Pancreatic Cancer

N Engl J Med. 2011 Feb 10;364514-523, JC Yao, et al

Mutant KRAS Associated With Lung, Brain Mets in CRC

Clin Cancer Res. 2011 Jan 14;[Epub Ahead of Print], J Tie, et al

Axel Grothey, MD: My Approach to Metastatic Colorectal Cancer

OncologySTAT Editorial Team. 2010 Sept 24, Interview by L Scott Zoeller
Read More

Bio

Biographical Sketch: 
Axel Grothey is a Professor of Oncology and Consultant in the Division of Medical Oncology in the Department of Oncology at the Mayo Clinic in Rochester, MN. He is the Vice Chair of the North Central Cancer Treatment Group (NCCTG) and the co-chair of the NCCTG GI committee.

After receiving his medical degree from Ruhr-University Bochum in Germany, Dr. Grothey completed his residency in internal medicine at the West-German Tumor Center at the University of Essen. He also completed residencies in pathology and internal medicine at prestigious universities in Germany and was awarded a fellowship in the Department of Hematology-Oncology at the University of Bochum. Subsequently, Dr. Grothey was awarded a postdoctoral research fellowship to address the effect of kinase-mediated signaling on the actin cytoskeleton and phenotypic properties of cancer cells at the MD Anderson Cancer Center at the University of Texas.

Dr. Grothey is a member of the Association of German Internists, the American Association of Cancer Research, the European Association for Cancer Research, the American Society for Cell Biology, the American Society of Clinical Oncology, and the European Society for Medical Oncology. He serves on the review board of numerous professional journals. In addition, he is widely published in many peer-reviewed journals. Dr. Grothey’s major areas of clinical interest are GI malignancies, in particular, colorectal cancer, unknown primaries, and neuroendocrine tumors.

Positions:
Professor of Oncology, Mayo Clinic 
Consultant, Division of Medical Oncology, Mayo Clinic

Degree: 
Ruhr-University Bochum, MD

Postgraduate Training:  
Postdoctoral research fellow, (PD McCrea, PhD), Department of Biochemistry and Molecular Biology, MD Anderson Cancer Center 
Postdoctoral fellow, Department of Hematology-Oncology, Ruhr-University Bochum
Resident, internal medicine, Department of Internal Medicine, Ruhr-University Bochum
Resident, Institute of Pathology, University of Duisburg-Essen
Resident, internal medicine, West-German Tumor Center, University of Duisburg-Essen

Board Certifications:  
ECFMG and USMLE 1, 2, and 3  
German Board of Internal Medicine  
German Board of Hematology/Oncology  
European Certificate in Medical Oncology  
European Society of Medical Oncology  
Educational Commission for Foreign Medical Graduates 

Clinical Interests:
Colorectal cancer, neuroendocrine tumors, unknown primaries

Comment Print page RSS feeds

Sign up for our newsletters

Too busy to follow cancer's top stories? Sign-up for one or more of our leading newsletters -- delivered weekly to your inbox.

Advisory and Editorial Boards

Meet OncologySTAT's Advisory and Editorial Boards that represent community practitioners and academic specialists with cross-disciplinary expertise.

Cancer Type

  • Bladder
  • Bone
  • Breast
  • Breast (ER-Positive)
  • CNS/Brain
  • Colon and Rectum
  • Endocrine System
  • Esophagus
  • GYN (Non-Ovary)
  • GYN (Ovary)
  • Head and Neck
  • Hodgkin's Lymphoma
  • Kidney (Renal Cell)
  • Leukemia
  • Liver and Bile Duct
  • Lung
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • Myeloproliferative Diseases
  • Non-Hodgkin's Lymphoma
  • Pancreas
  • Pediatric Cancers
  • Prostate
  • Rare Cancers
  • Skin
  • Soft-Tissue Sarcoma
  • Stomach
  • Testicle
  • Forgot your password?
    Not a member? Free registration